Junji Tsurutani
Junji Tsurutani publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology and Advanced Breast Cancer Therapies.
- World rank
- #231,024 of 7,710,434 ranked researchers
- Rank in Japan
- #1,795 of 383,136
- Works
- 379
- Citations
- 20k
- Citations per work
- 51.6
What does Junji Tsurutani research?
Junji Tsurutani's work is mostly in Medicine (65%), Biochemistry, Genetics and Molecular Biology (16%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences24765.1%
- Medicine24765.1%
- Everything else7319.3%
- Life Sciences5915.6%
- 1Oncology38% of their works
- 2Pulmonary and Respiratory Medicine21% of their works
- 3Molecular Biology8% of their works
- 4Cancer Research8% of their works
- 5Radiology, Nuclear Medicine and Imaging3% of their works
- 6Surgery3% of their works
Research topics
Which keywords describe Junji Tsurutani's research?
The keywords of their largest research topics: Breast Cancer, Metastatic Breast Cancer, Chemotherapy, HER2, Trastuzumab, Chemotherapy-Induced Peripheral Neuropathy, Taxanes and CDK4/6 Inhibitors.
- Small-Cell Lung Cancer
- Immune Checkpoint Blockade
- KRAS Mutations
- Gene Expression
- EGFR Mutations
- Molecular Subtypes
- Clinical Trials
- CDK4/6 Inhibitors
- Chemotherapy-Induced Peripheral Neuropathy
- HER2
- Metastatic Breast Cancer
- Breast Cancer
- Chemotherapy
- Trastuzumab
- Taxanes
- Palbociclib
- Targeted Therapy
- ALK Inhibitors
- Breast Tumours
- Cetuximab
- Genomic Profiles
- PD-1 and PD-L1
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Breast Cancer2262 topics
- Metastatic Breast Cancer1992 topics
- Chemotherapy1823 topics
- HER21291 topic
- Trastuzumab1291 topic
- Chemotherapy-Induced Peripheral Neuropathy1021 topic
- Taxanes1021 topic
- CDK4/6 Inhibitors971 topic
- Palbociclib971 topic
- Clinical Trials812 topics
- Targeted Therapy812 topics
- Molecular Subtypes792 topics
- ALK Inhibitors571 topic
- EGFR Mutations571 topic
- Breast Tumours501 topic
- Gene Expression501 topic
- Cetuximab291 topic
- KRAS Mutations291 topic
- Genomic Profiles241 topic
- Immune Checkpoint Blockade241 topic
- PD-1 and PD-L1241 topic
- Small-Cell Lung Cancer241 topic
Where does Junji Tsurutani work?
Junji Tsurutani's main affiliation in the publication record is Kindai University, Japan.
How many publications and citations does Junji Tsurutani have?
OpenAlex counts 379 works and 19,559 citations for Junji Tsurutani, an h-index of 53, ranking #231,024 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Junji Tsurutani. Posts are plain text and can be reported.